Back to Search
Start Over
[Glivek in the therapy of some forms of Ph- and bcr/abl-negative myeloproliferative diseases and a myeloproliferative variant of idiopathic hypereosinophilic syndrome].
- Source :
-
Terapevticheskii arkhiv [Ter Arkh] 2004; Vol. 76 (7), pp. 87-90. - Publication Year :
- 2004
- Subjects :
- Adult
Benzamides
Eosinophils drug effects
Humans
Hypereosinophilic Syndrome blood
Hypereosinophilic Syndrome genetics
Imatinib Mesylate
Leukocyte Count
Male
Middle Aged
Myeloproliferative Disorders blood
Myeloproliferative Disorders genetics
Piperazines administration & dosage
Polymerase Chain Reaction
Pyrimidines administration & dosage
Treatment Outcome
Fusion Proteins, bcr-abl analysis
Hypereosinophilic Syndrome drug therapy
Myeloproliferative Disorders drug therapy
Philadelphia Chromosome
Piperazines therapeutic use
Pyrimidines therapeutic use
Subjects
Details
- Language :
- Russian
- ISSN :
- 0040-3660
- Volume :
- 76
- Issue :
- 7
- Database :
- MEDLINE
- Journal :
- Terapevticheskii arkhiv
- Publication Type :
- Academic Journal
- Accession number :
- 15379136